Regular use of aspirin is associated with a lower cardiovascular risk in prostate cancer patients receiving gonadotropin-releasing hormone therapy

Gonadotropin-releasing hormone (GnRH) therapy has been known to increase risks of major adverse cardiovascular and cerebrovascular events (MACCEs). Herein, we aim to estimate whether regular use of aspirin attenuates risks of MACCEs in prostate cancer patients receiving GnRHs. Using Taiwanese Nation...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Wei-Ting, Hong, Chon-Seng, Hsieh, Kun-Lin, Chen, Yi-Chen, Ho, Chung−Han, Shih, Jhih-Yuan, Kan, Wei-Chih, Chen, Zhih-Cherng, Lin, You-Cheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511956/
https://www.ncbi.nlm.nih.gov/pubmed/36172150
http://dx.doi.org/10.3389/fonc.2022.952370

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511956/
https://www.ncbi.nlm.nih.gov/pubmed/36172150
http://dx.doi.org/10.3389/fonc.2022.952370

Ejemplares similares